• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
98% Bifida Ferment Lysate
rhSOD (cosmetic grade)
Recombinant humanized collagen
Recombinant Humanized Small-molecule Collagen
Recombinant Humanized Small-molecule Collagen Solution
rhSOD

Glenmark Pharma gets ANDA approval for Tacrolimus Capsules

expresspharmaNovember 12, 2020

Tag: ANDA , Glenmark , Astellas , Tacrolimus Capsules

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (US FDA) for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg, the generic version of Prograf Capsules, 0.5 mg, 1 mg and 5 mg, of Astellas Pharm US, Inc.

According to IQVIA, sales data for the 12 month period ending September 2020, the Prograf Capsules, 0.5 mg, 1 mg and 5 mg market2 achieved annual sales of approximately $286.8 million.

Glenmark’s current portfolio consists of 166 products authorised for distribution in the US marketplace and 45 ANDA’s pending approval with the US FDA.

Previous:Sputnik V vaccine shows 92 per cent efficacy in ongoing phase III trials in Russia

Next:SCHOTT Glass India inaugurates new glass melting tank at Gujarat facility

Related News

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

A New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

Glenmark Pharma gets ANDA approval for Tacrolimus Capsules | Pharmasources.com

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

PRNewswireDecember 21, 2024

Corvia Medical, Inc.announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745).

You may like
More>>

8000L Standard Steam/Oil Heating Carbon steel Glass Lined Reactor

8000L Standard Steam/Oil Heating Carbon steel Glass Lined Reactor
LGJ-18S Multi Manifold Standard Type Experimental Freeze Dryer

LGJ-18S Multi Manifold Standard Type Experimental Freeze Dryer
Mini MR standard

Mini MR standard
Standard endotracheal tube

Standard endotracheal tube
Refrigerated Circulators with Standard Digital Temperature Controllers

Refrigerated Circulators with Standard Digital Temperature Controllers
99% up USP standard Exemestane 107868-30-4

99% up USP standard Exemestane 107868-30-4
Standard External Control ...

Standard External Control ...
Standard Nozzle

Standard Nozzle
Linbel DLSB-5-30 Standard Working Cycle Cooler On Sale

Linbel DLSB-5-30 Standard Working Cycle Cooler On Sale
Factory supply Good Price Thymalfasin fandachem Thymosin α1 API Thymosin Alpha 1 Powder CAS 62304-98

Factory supply Good Price Thymalfasin fandachem Thymosin α1 API Thymosin Alpha 1 Powder CAS 62304-98

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service